BioCentury
ARTICLE | Clinical News

2B3-101: Phase I/IIa data

October 14, 2013 7:00 AM UTC

Data from 25 patients with brain metastases from solid tumors or recurrent malignant glioma in the Phase I portion of an open-label, dose-escalation, international Phase I/IIa trial showed that 5-60 m...